222 results
Page 3 of 12
6-K
EX-99.1
84dn4
21 Dec 22
Current report (foreign)
6:01am
6-K
EX-99.1
iee8i ga58g
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
mpomau z48j
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
ucg0kar6994083p
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
haw n0kbrf8
30 Nov 22
Current report (foreign)
6:28am
6-K
EX-99.1
hnwa6b
27 Oct 22
Current report (foreign)
6:01am
6-K
zmpeuvgshw
27 Oct 22
Current report (foreign)
6:01am
6-K
v15plgs 3zut
14 Oct 22
Current report (foreign)
7:36am
6-K
v2wr4yl8lysoxot
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
v3088j3izyqd4
23 Aug 22
Current report (foreign)
6:13am
6-K
EX-99.1
r35574n h3m
4 Aug 22
Current report (foreign)
6:07am
6-K
foxpvgo6mgqyo9p
28 Jul 22
Current report (foreign)
6:09am
6-K
EX-99.1
bq3hb1kezt0vgzs guv7
28 Jul 22
Current report (foreign)
6:09am
6-K
frm b3lyxm4
11 Jul 22
Current report (foreign)
6:05am
6-K
dzf5b9
5 Jul 22
Current report (foreign)
6:09am
6-K
rrboh
29 Jun 22
Current report (foreign)
6:02am
6-K
qc4odbw r8wig
29 Jun 22
Current report (foreign)
6:01am
6-K
ewfzt uzjlnqjq2ig
31 May 22
Current report (foreign)
6:20am
6-K
EX-99.1
4wbwugz4qidqyhs0
31 May 22
Current report (foreign)
6:07am